Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reproductive and Genetic Hospital of CITIC-Xiangya is a premier specialized medical institution in China, recognized globally for its expertise in assisted reproductive technology (ART) and clinical genetics. Founded in 2002 as a joint venture between CITIC Group and Central South University, it evolved from the first human sperm bank in China established by Professor Lu Guangxiu. The hospital performs tens of thousands of IVF cycles annually, maintaining some of the highest clinical pregnancy rates in the industry. Its core services include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and advanced preimplantation genetic testing (PGT) for over 1,000 types of genetic diseases. Additionally, the institution houses a major human embryonic stem cell bank and conducts cutting-edge research in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reproductive and Genetic Hospital of CITIC-Xiangya.